Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia
In: Annals of Hematology Annals of Hematology, Springer Verlag, 2011, 90 (8), pp.939-946. ⟨10.1007/s00277-011-1179-2⟩; (2011-02-18)
Online
unknown
Zugriff:
This study investigates the differential gene expression profile of JAK2(V617F)-positive myeloproliferative neoplasm (MPN) patients, with and without response to hydroxyurea (HU) treatment. Twenty-one polycythemia vera, 28 essential thrombocythemia, eight secondary erythrocytosis, and 30 controls were studied. Thirty-four genes were overexpressed in patients who did not respond to HU. Of these, some participate in proliferative pathways: MAPK, AKT, Src kinase (SFK), and JAK2 pathway. JAK2 allele burden was similar between groups of responders and nonresponder. A molecular fingerprint distinguishes JAK2(V617F)-positive MPN patients without response to HU treatment, with overexpression of JAK2, MAPK14, PIK3CA, and SFK genes.
Titel: |
Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia
|
---|---|
Autor/in / Beteiligte Person: | Rueda, Daniel ; Jiménez, Ana ; Albizua, Enriqueta ; Florensa, Lourdes ; Ayala, Rosa ; Martinez-Lopez, Joaquin ; Rapado, Inmaculada ; Espinet, Blanca ; Besses, Carles ; Gallardo, Miguel ; Barrio, Santiago ; Sanchez-Espiridion, Beatriz ; Puigdecanet, Eulàlia ; Servicio de Hematología ; Hospital Universitario 12 de Octubre [Madrid] ; Servicio de Hematología, Hospital Virgen de la Salud ; Spanish National Cancer Research Center (CNIO) ; Laboratoris de Citologia Hematológica/Citogenética Molecular. Servei de Patologia, GRETNHE ; IMIM-Hospital del Mar |
Link: | |
Quelle: | Annals of Hematology Annals of Hematology, Springer Verlag, 2011, 90 (8), pp.939-946. ⟨10.1007/s00277-011-1179-2⟩; (2011-02-18) |
Veröffentlichung: | HAL CCSD, 2011 |
Medientyp: | unknown |
ISSN: | 0939-5555 (print) ; 1432-0584 (print) |
Schlagwort: |
|
Sonstiges: |
|